BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11507190)

  • 1. Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution.
    Kuhmann SE; Madani N; Diop OM; Platt EJ; Morvan J; Müller-Trutwin MC; Barré-Sinoussi F; Kabat D
    J Virol; 2001 Sep; 75(18):8449-60. PubMed ID: 11507190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
    Kuhmann SE; Platt EJ; Kozak SL; Kabat D
    J Virol; 1997 Nov; 71(11):8642-56. PubMed ID: 9343222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.
    Riddick NE; Wu F; Matsuda K; Whitted S; Ourmanov I; Goldstein S; Goeken RM; Plishka RJ; Buckler-White A; Brenchley JM; Hirsch VM
    J Virol; 2015 Dec; 90(5):2316-31. PubMed ID: 26656714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIVagm: genetic and biological features associated with replication.
    Müller MC; Barré-Sinoussi F
    Front Biosci; 2003 Sep; 8():d1170-85. PubMed ID: 12957815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys.
    Müller MC; Saksena NK; Nerrienet E; Chappey C; Hervé VM; Durand JP; Legal-Campodonico P; Lang MC; Digoutte JP; Georges AJ
    J Virol; 1993 Mar; 67(3):1227-35. PubMed ID: 8437214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.
    Pöhlmann S; Lee B; Meister S; Krumbiegel M; Leslie G; Doms RW; Kirchhoff F
    J Virol; 2000 Jun; 74(11):5075-82. PubMed ID: 10799581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo.
    Müller-Trutwin MC; Corbet S; Tavares MD; Hervé VM; Nerrienet E; Georges-Courbot MC; Saurin W; Sonigo P; Barré-Sinoussi F
    Virology; 1996 Sep; 223(1):89-102. PubMed ID: 8806543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells.
    Owen SM; Masciotra S; Novembre F; Yee J; Switzer WM; Ostyula M; Lal RB
    J Virol; 2000 Jun; 74(12):5702-8. PubMed ID: 10823878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simian immunodeficiency virus infection in a patas monkey (Erythrocebus patas): evidence for cross-species transmission from African green monkeys (Cercopithecus aethiops sabaeus) in the wild.
    Bibollet-Ruche F; Galat-Luong A; Cuny G; Sarni-Manchado P; Galat G; Durand JP; Pourrut X; Veas F
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():773-81. PubMed ID: 8627266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm.
    Ploquin MJ; Diop OM; Sol-Foulon N; Mortara L; Faye A; Soares MA; Nerrienet E; Le Grand R; Van Kooyk Y; Amara A; Schwartz O; Barré-Sinoussi F; Müller-Trutwin MC
    J Virol; 2004 Jan; 78(2):798-810. PubMed ID: 14694112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
    Siciliano SJ; Kuhmann SE; Weng Y; Madani N; Springer MS; Lineberger JE; Danzeisen R; Miller MD; Kavanaugh MP; DeMartino JA; Kabat D
    J Biol Chem; 1999 Jan; 274(4):1905-13. PubMed ID: 9890944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors.
    Pöhlmann S; Davis C; Meister S; Leslie GJ; Otto C; Reeves JD; Puffer BA; Papkalla A; Krumbiegel M; Marzi A; Lorenz S; Münch J; Doms RW; Kirchhoff F
    J Virol; 2004 Apr; 78(7):3223-32. PubMed ID: 15016843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid Dendritic Cell Infection and Sensing Capacity during Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infection.
    Jochems SP; Jacquelin B; Chauveau L; Huot N; Petitjean G; Lepelley A; Liovat AS; Ploquin MJ; Cartwright EK; Bosinger SE; Silvestri G; Barré-Sinoussi F; Lebon P; Schwartz O; Müller-Trutwin MC
    J Virol; 2015 Jul; 89(13):6918-27. PubMed ID: 25903334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites.
    Pandrea I; Parrish NF; Raehtz K; Gaufin T; Barbian HJ; Ma D; Kristoff J; Gautam R; Zhong F; Haret-Richter GS; Trichel A; Shaw GM; Hahn BH; Apetrei C
    J Virol; 2012 Apr; 86(8):4158-68. PubMed ID: 22318138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild.
    Ma D; Jasinska AJ; Feyertag F; Wijewardana V; Kristoff J; He T; Raehtz K; Schmitt CA; Jung Y; Cramer JD; Dione M; Antonio M; Tracy R; Turner T; Robertson DL; Pandrea I; Freimer N; Apetrei C;
    J Virol; 2014 May; 88(10):5687-705. PubMed ID: 24623416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.
    Pandrea I; Kornfeld C; Ploquin MJ; Apetrei C; Faye A; Rouquet P; Roques P; Simon F; Barré-Sinoussi F; Müller-Trutwin MC; Diop OM
    J Virol; 2005 May; 79(10):6249-59. PubMed ID: 15858009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.